Evaluation of the Inclisiran Safety in High-Risk Populations
J Am Coll Cardiol
.
2024 Apr 2;83(13):e127.
doi: 10.1016/j.jacc.2023.12.037.
Epub 2024 Mar 25.
Authors
Xin Jiang
1
,
Zhengjun Zhang
1
,
Hao Ding
2
Affiliations
1
Baoying People's Hospital, Baoying, Yang-Zhou, Jiangsu Province, China.
2
Baoying People's Hospital, Baoying, Yang-Zhou, Jiangsu Province, China; Baoying Maternal and Child Health Hospital, Baoying, Yangzhou, Jiangsu Province, China. Electronic address: dinhao771017@163.com.
PMID:
38538206
DOI:
10.1016/j.jacc.2023.12.037
No abstract available
Publication types
Letter
MeSH terms
Anticholesteremic Agents*
Humans
Hypercholesterolemia*
Proprotein Convertase 9
RNA, Small Interfering
Substances
ALN-PCS
Anticholesteremic Agents
RNA, Small Interfering
Proprotein Convertase 9